| Literature DB >> 29739449 |
Roberto Sánchez-Sánchez1, Ignacio Ferre1, Michela Re2, Javier Regidor-Cerrillo1, Javier Blanco-Murcia2, Luis Miguel Ferrer3, Teresa Navarro3, Manuel Pizarro Díaz2, Marta González-Huecas2, Enrique Tabanera2, Julio Benavides4, Luis Miguel Ortega-Mora5.
Abstract
Experimental infections in pregnant sheep have been focused on studying the effect of the time of challenge on the outcome of N. caninum infection, whereas the impact of the dose and route of challenge has not been studied in depth. Therefore, clinical outcome, immune responses, parasite detection and burden, and lesion severity in placental tissues and foetal brains were investigated in 90-day-pregnant sheep inoculated intravenously with 105 (G1), 104 (G2), 103 (G3), or 102 (G4) tachyzoites or subcutaneously with 104 (G5) tachyzoites of the virulent Nc-Spain7 isolate and an uninfected group (G6). Comparing challenge doses, G1 was the only group that had 100% abortion. Likewise, IFNγ levels in G1 increased earlier than those in other intravenously infected groups, and IgG levels on day 21 post-infection (pi) were higher in G1 than those in other intravenously infected groups. Concerning vertical transmission, G1 shows a higher parasite burden in the foetal brain than did G2 and G3. Comparing routes of administration, no differences in foetal survival rate or parasite load in the foetal brain were found. Although G2 had higher IFNγ levels than G5 on day 10 pi, no differences were found in humoral immune responses. Because the outcome after intravenous infection with 105 tachyzoites was similar to that observed after intravenous infection with 106 tachyzoites used in a previous work (100% abortion and vertical transmission), we conclude that it may be reasonable to use 105 tachyzoites administered by the intravenous route in further experiments when assessing drugs or vaccine candidates.Entities:
Mesh:
Year: 2018 PMID: 29739449 PMCID: PMC5941812 DOI: 10.1186/s13567-018-0539-5
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Experimental design
| Group | Number of pregnant ewes | Number of foetuses | Ratio foetuses/dam | Inoculum | Route of inoculation |
|---|---|---|---|---|---|
| G1 | 6 | 12 | 2 | Nc-Spain7 | IV |
| G2 | 5 | 11 | 2.20 | Nc-Spain7 | IV |
| G3 | 5 | 13 | 2.60 | Nc-Spain7 | IV |
| G4 | 4 | 7 | 1.75 | Nc-Spain7 | IV |
| G5 | 4 | 8 | 2 | Nc-Spain7 | SC |
| G6 | 3 | 5 | 1.66 | PBS | IV |
IV intravenous route, SC subcutaneous route
Detection of parasite DNA, parasite load and histopathological changes in foetal brains and placental tissues from sheep and serological analysis of the foetuses after challenge infection with the Nc-Spain7 isolate at mid-gestation
| Group | Animal id. | Foetal death (days pi)a | Placentomes/cotyledonsb | Foetal brain | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foetus/lamb 1 | Foetus/lamb 2 | Foetus/lamb 3 | Foetus/lamb 4 | ||||||||||||||||||
| HPc | DNAe | qPCRf | IFATd | HPc | DNAe | qPCRf | IFATd | HPc | DNAe | qPCRf | IFATd | HPc | DNAe | qPCRf | IFATd | HPc | DNAe | qPCRf | |||
| Group 1 (105 tachyzoites, IV) | 1.1 | 38 | +++ | 6/6 | 2030.18 ± 2021.53 | 1:32 | +++ | 3/3 | 47.53 ± 22.41 | 1:256 | * | 0/3 | 0.01 | ||||||||
| 1.2 | 40 | +++ | 6/6 | 1990.74 ± 543.90 | 1:256 | ++ | 2/3 | 3.40 ± 3.01 | |||||||||||||
| 1.3 | 40 | ++ | 6/6 | 3355.17 ± 2407.07 | 1:1024 | +++ | 3/3 | 8.47 ± 2.67 | |||||||||||||
| 1.4 | 37 | ++ | 6/6 | 2028.50 ± 2434.11 | 1:128 | ++ | 2/3 | 14.42 ± 13.01 | 1:256 | +++ | 3/3 | 584.97 ± 403.74 | 1:32 | * | 3/3 | 97.72 ± 109.14 | β | β | β | β | |
| 1.5 | 35 | +++ | 6/6 | 3296.38 ± 1231.41 | 1:64 | +++ | 3/3 | 141.14 ± 69.34 | 1:32 | * | 3/3 | 56.18 ± 27.50 | |||||||||
| 1.6 | 38 | +++ | 6/6 | 7974.29 ± 4660.05 | 1:1024 | ++ | 2/3 | 13.26 ± 15.57 | 1:1024 | ++ | 3/3 | 16.86 ± 10.67 | |||||||||
| Group 2 (104 tachyzoites, IV) | 2.1 | 32 | +++ | 6/6 | 7420.68 ± 6570.82 | 1:256 | ++ | 3/3 | 13.38 ± 6.04 | ||||||||||||
| 2.2 | NA | 4/4γ | 3992.48 ± 1562.24γ | 1:800 | + | 2/3 | 5.16 ± 5.59 | β | β | β | β | β | β | β | β | ||||||
| 2.3 | 32 | +++ | 6/6 | 4548.31 ± 4733.95 | 1:128 | + | 3/3 | 19.61 ± 12.04 | |||||||||||||
| 2.4 | 37 | + | 6/6 | 1930.36 ± 2034.10 | 1:256 | ++ | 2/3 | 5.54 ± 6.06 | β | β | β | β | |||||||||
| 2.5 | 42 | +++ | 6/6 | 6829.41 ± 3917.31 | 1:64 | + | 3/3 | 2.70 ± 0.86 | 1:64 | ++ | 3/3 | 20.29 ± 8.74 | NA | ++ | 3/3 | 11.97 ± 10.24 | 1:128 | ++ | 3/3 | 3.31 ± 2.49 | |
| Group 3 (103 tachyzoites, IV) | 3.1 | 39 | ++ | 6/6 | 12 260.49 ± 9266.82 | 1:32 | ++ | 3/3 | 9. 48 ± 5.47 | 1:256 | ++ | 3/3 | 23.56 ± 13.52 | ||||||||
| 3.2 | 42 | ++ | 6/6 | 7370.42 ± 9178.25 | 1:256 | ++ | 3/3 | 2.27 ± 0.73 | 1:512 | ++ | 0/3 | 0.01 | |||||||||
| 3.3 | 44 | ++ | 6/6 | 2307.22 ± 1754.57 | 1:256 | ++ | 3/3 | 39.60 ± 43.86 | 1:128 | ++ | 0/3 | 0.01 | |||||||||
| 3.4 | NA | 5/6 | 62.07 ± 95.88 | 1:400 | ++ | 2/3 | 3.07 ± 2.72 | 1:400 | ++ | 2/3 | 3.33 ± 3.52 | 1:200 | + | 0/3 | 0.01 | 1:256 | + | 1/3 | 0.67 ± 1.15 | ||
| 3.5 | NA | 6/6 | 823.41 ± 714.63 | 1:1024 | ++ α | 3/3 | 7.74 ± 3.20 | 1:256 | + | 3/3 | 6.54 ± 0.30 | 1:64 | ++ | 3/3 | 15.91 ± 7.92 | ||||||
| Group 4 (102 tachyzoites, IV) | 4.1 | NA | 6/6 | 1334.88 ± 561.06γ | 1:400 | + | 3/3 | 12.44 ± 7.18 | 1:64 | * | 3/3 | 37.24 ± 17.02 | |||||||||
| 4.2 | NA | 6/6 | 6160.29 ± 4646.09γ | 1:400 | + | 1/3 | 1.22 ± 2.11 | ||||||||||||||
| 4.3 | 35 | ++ | 6/6 | 2101.24 ± 1290.86γ | 1:512 | ++ | 3/3 | 23.03 ± 3.12 | 1:1024 | ++ | 3/3 | 14.35 ± 12.77 | |||||||||
| 4.4 | 42 | ++ | 6/6 | 3226.22 ± 2350.13γ | 1:512 | ++ | 3/3 | 45.58 ± 22.09 | 1:128 | ++ | 3/3 | 20.07 ± 13.80 | |||||||||
| Group 5 (104 tachyzoites, SC) | 5.1 | NA | 6/6 | 65.40 ± 27.49γ | 1:800 | + | 3/3 | 3.87 ± 1.85 | 1:200 | + | 1/3 | 0.65 ± 1.12 | 1:800 | + | 3/3 | 7.22 ± 5.87 | |||||
| 5.2 | 35 | + | 6/6 | 707.20 ± 614.80 | 1:512 | ++ | 3/3 | 16.07 ± 2.49 | 1:256 | ++ α | 2/3 | 2.62 ± 2.31 | |||||||||
| 5.3 | 32 | +++ | 6/6 | 38 294.17 ± 23 816.82 | 1:512 | +++ | 3/3 | 114.35 ± 34.34 | |||||||||||||
| 5.4 | 37 | + | 6/6 | 781.48 ± 444.87γ | 1:128 | + | 3/3 | 6.32 ± 5.64 | 1:256 | ++ | 3/3 | 2.81 ± 1.58 | |||||||||
| Group 6 (uninfected) | 6.1 | NA | 0/6 | 0.01 | – | – | 0/3 | 0.01 | – | – | 0/3 | 0.01 | |||||||||
| 6.2 | NA | 0/6 | 0.01 | – | – | 0/3 | 0.01 | – | – | 0/3 | 0.01 | ||||||||||
| 6.3 | NA | 0/6 | 0.01 | – | – | 0/3 | 0.01 | ||||||||||||||
aDay post-challenge when foetal death was detected by ultrasonography. The remaining foetuses lived until the end of the experiment
bPlacentomes in ewes that aborted and cotyledons in ewes that gave birth; “NA” samples from cotyledons were not evaluated for histopathology
cHistopathological lesion severity: none detected/unrelated (−), mild lesions (+) (in placentome, 0–33.3% of the placentome show lesions; in foetal brain, presence of local encephalitis), moderate lesions (++) (in placentome, 33.3–66.6% of the placentome show lesions; in foetal brain, presence of diffuse encephalitis) and severe lesions of ovine neosporosis (+++) (in placentome, 66.6–99.9% of the placentome show lesions; in foetal brain, presence of diffuse encephalitis and necrosis). * Autolysed; α No histopathological changes were found in one of the slides analysed
dIFAT IgG antibody titres in foetal body fluids and in precolostral serum collected after birth in lambs born alive; “NA” not available
eFractions represent the number of positive samples by nested PCR/number of samples examined
fMean parasite load (tachyzoites/mg tissue) and standard deviation (SD). Considering that the N. caninum detection limit by real-time PCR is 0.1 parasites, negative samples (0 parasites) were represented as 0.01
βMummified foetuses were not evaluated for any of the parameters
γSamples from placental tissues exhibiting DNA degradation were excluded from parasite detection and/or parasite load analysis
Figure 1Foetal survival curves. Foetal survival curves from intravenously challenged animals (A) and from IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each point represents the percentage of surviving animals on that day, and downward steps correspond to observed deaths. Foetal survival curves were compared by the log-rank (Mantel–Cox) test. For significant differences between foetal survival curves of infected groups, (*) indicates P < 0.05.
Figure 2Rectal temperatures after challenge in pregnant ewes. A Rectal temperatures in intravenously challenged animals (A) and in IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each point represents the mean + SD at different times for each group. Rectal temperatures represented in figure were analysed using two-way ANOVA of repeated measures.
Figure 3Systemic IFNγ response after challenge in pregnant ewes. IFNγ response in intravenously challenged animals (A) and in IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each point represents the mean + SD at the different sampling times for each group. IFNγ levels from G1 on day 10 pi are not available due to problems in antigen stimulation assays of the peripheral blood. Data beyond day 28 pi are not included because several animals did not maintain pregnancy and were therefore sacrificed. Concentrations of IFNγ are expressed in pg/mL. The cellular immune response represented in figure was analysed using two-way ANOVA of repeated measures. For significant differences between infected groups, (***) indicates P < 0.001, and (****) indicates P < 0.0001.
Figure 4Anti- IgG response in serum. IgG response in intravenously challenged animals (A) and in IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each point represents the mean + SD at the different sampling times for each group. Data beyond day 28 pi are not included because several animals did not maintain pregnancy and were therefore sacrificed. Serum levels of total IgG antibodies against N. caninum are expressed as a relative index percent (RIPC), according to the formula: RIPC = (OD405 sample − OD405 negative control)/(OD405 positive control − OD405 negative control) × 100. The humoral immune response shown in figure was analysed using two-way ANOVA of repeated measures. For significant differences between infected groups, (*) indicates P < 0.05 and (****) indicates P < 0.0001.
Figure 5Dot-plot graphs of burdens in placentomes. N. caninum burden in placentomes from intravenously challenged dams (A) and from IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each dot represents individual values of parasite burden (number of parasites per mg of host tissue), and medians are represented as horizontal lines. Considering that the N. caninum detection limit by real-time PCR is 0.1 parasites, negative samples (0 parasites) were represented on the log scale as < 0.1 (i.e., 10−2). Parasite burdens were analysed using the non-parametric Kruskal–Wallis test followed by the Dunn’s test for comparisons between groups, as well as the Mann–Whitney test for pairwise comparisons.
Figure 6Dot-plot graphs of burdens in cotyledons. N. caninum burden in cotyledons from intravenously challenged dams (A) and from IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each dot represents individual values of parasite burden (number of parasites per mg of host tissue), and medians are represented as horizontal lines. Considering that the N. caninum detection limit by real-time PCR is 0.1 parasites, negative samples (0 parasites) were represented on the log scale as < 0.1 (i.e., 10−2). Parasite burdens were analysed using the non-parametric Kruskal–Wallis test followed by the Dunn’s test for comparisons between groups, as well as the Mann–Whitney test for pairwise comparisons. (**) indicates P < 0.01, (***) P < 0.001, and (ρ) indicates a trend towards significant differences among infected groups in each tissue.
Figure 7Dot-plot graphs of burdens in foetal brain. N. caninum burden in foetal brain from intravenously challenged dams (A) and from IV and SC challenged animals with 104 Nc-Spain7 tachyzoites (B). Each dot represents individual values of parasite burden (number of parasites per mg of host tissue), and medians are represented as horizontal lines. Considering that the N. caninum detection limit by real-time PCR is 0.1 parasites, negative samples (0 parasites) were represented on the log scale as < 0.1 (i.e., 10−2). Parasite burdens were analysed using the non-parametric Kruskal–Wallis test followed by the Dunn’s test for comparisons between groups, as well as the Mann–Whitney test for pairwise comparisons. (*) indicates P < 0.05, (***) P < 0.001, and (ρ) indicates a trend towards significant differences among infected groups in each tissue.